ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
4.460
-0.170 (-3.67%)
Oct 31, 2025, 4:00 PM EST - Market closed
ADC Therapeutics Market Cap
ADC Therapeutics has a market cap or net worth of $501.75 million as of November 3, 2025. Its market cap has increased by 61.16% in one year.
Market Cap
501.75M
Enterprise Value
687.95M
1-Year Change
61.16%
Ranking
Category
Stock Price
$4.46
Market Cap Chart
Since May 15, 2020, ADC Therapeutics's market cap has decreased from $2.04B to $501.75M, a decrease of -75.44%. That is a compound annual growth rate of -22.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 501.75M | 160.77% |
| Dec 31, 2024 | 192.41M | 43.49% |
| Dec 29, 2023 | 134.10M | -56.31% |
| Dec 30, 2022 | 306.95M | -80.20% |
| Dec 31, 2021 | 1.55B | -37.60% |
| Dec 31, 2020 | 2.48B | 21.63% |
| May 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |